The 7th International Conference “Complex treatment of plasma cell dyscrasia in 2018” is a traditional scientific meeting organized in Cracow by Myeloma Treatment Foundation Center, Cracow Branch of the Polish Society of Hematology and Transfusion Medicine, and the Department of Hematology, Jagiellonian University. Program of the Conference focuses on interdisciplinary and multimodal therapy of patients with amyloidosis, multiple myeloma, Waldenström’s disease. This year's edition of the conference will also be a meeting of the Polish Myeloma Study Group of the Polish Society of Hematology and Blood Transfusion.
Actually invitation to Małopolska has been accepted by outstanding specialists from the United States, Israel and France, which confirms that medicine knows no borders and that mutual intellectual stimulation is above any national differences. We are delighted to host such widely recognized researchers in Cracow, the location of the oldest hematological center In Poland. We hope that our Guests will have an opportunity to enjoy the beauty of the historical capital of Poland, and to visit a unique site, the Salt Mine in Wieliczka.
We would like to thank Alvogen Poland Sp. z o.o., Amgen Biotechnologia Sp. z o.o., Biokom Baka Olszewski Sp. jawna, Celgene Sp. z o.o., CSL Behring Sp. z o.o., Karyopharm, Takeda Polska Sp. z o.o., Janssen-Cilag Polska Sp. z o.o. and Sanofi-Aventis Sp. z o.o. for supporting us in organization of this Conference.
We hope that this meeting will contribute to the development of modern treatment of plasma cell dyscrasia in Poland, where many innovative therapies are still not reimbursed. We provide for all guests accommodation in Krakow and other activities during the conference. Please sign up through the page www.szpiczak2018.jordan.pl.
Artur Jurczyszyn, M.D., Ph.D., Associate Professor
Professor Aleksander B. Skotnicki, M.D., Ph.D